Assessment of prenatal tobacco smoke exposure by determining nicotine and its metabolites in meconium

Human and Experimental Toxicology

Volumn 26, Issue 6, 2007, Pages 535-544

  Köhler, Elke ^a   Avenarius, S ^a   Rabsilber, A ^a   Gerloff, C ^a   Jorch, G ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Cotinine; Meconium; Nicotine; Prenatal smoke exposure; Trans 3 hydroxycotinine; Urine

Indexed keywords

3 HYDROXYCOTININE; COTININE; NICOTINE; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ARTICLE; ENVIRONMENTAL EXPOSURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MATERNAL SMOKING; MECONIUM; NEWBORN; PRENATAL EXPOSURE; PRIORITY JOURNAL; SMOKING CESSATION; URINALYSIS;

ADOLESCENT; ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COTININE; DATA INTERPRETATION, STATISTICAL; ENVIRONMENTAL EXPOSURE; FEMALE; GERMANY; HUMANS; INFANT, NEWBORN; MATERNAL EXPOSURE; MECONIUM; NICOTINE; PREGNANCY; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TOBACCO SMOKE POLLUTION; TOXICOLOGY; URINALYSIS;

NICOTIANA TABACUM;

EID: 34547670513     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327107072391     Document Type: Article

References (29)

1. Castles A, Adams EK, Melvin CL, Kelsch C, Boulton ML, Effects of smoking during pregnancy. Five meta-analyses. American Journal of Preventive Medicine 1999; 16: 208-15.
2. Jong-Pley EA, Wouters EJ, de Jong PA, Voorhorst FJ, Stolte SB, Kurver PH. Effects of maternal smoking on neonatal morbidity. Journal of Perinatal Medicine 1994; 22: 93-101.
3. Wang X, Tager IB, Van Vunakis H, Speizer FE, Hanrahan JP. Maternal smoking during pregnancy, urine cotinine concentrations, and birth outcomes. A prospective cohort study. International Journal of Epidemiology 1997; 26: 978-88.
4. Schellscheidt J, Jorch G, Menke J. Effects of heavy maternal smoking on intrauterine growth patterns in sudden infant death victims and surviving infants. European Journal of Pediatrics 1998; 157: 246-51.
5. Schellscheidt J, Oyen N, Jorch G. Interactions between maternal smoking and other prenatal risk factors for sudden infant death syndrome (SIDS). Acta Paediatrica 1997; 86: 857-63.
6. Nuesslein TG, Beckers D, Rieger CH. Cotinine in meconium indicates risk for early respiratory tract infections. Human and Experimental Toxicology 1999; 18: 283-90.
7. Klebanoff MA, Levine RJ, Clemens JD, DerSimonian R, Wilkins DG. Serum cotinine concentration and self-reported smoking during pregnancy. American Journal of Epidemiology 1998; 148: 259-62.
8. Parazzini F, Davoli E, Rabaiotti M, Restelli S, Stramare L, Dindelli M, La Vecchia C, Fanelli R. Validity of self-reported smoking habits in pregnancy: a saliva cotinine analysis. Acta Obstetricia et Gynecologica Scandinavica 1996; 75: 352-54.
9. Nafstad P, Kongerud J, Botten G, Urdal P, Silsand T, Pedersen BS, Jaakkola JJ. Fetal exposure to tobacco smoke products: a comparison between self-reported maternal smoking and concentrations of cotinine and thiocyanate in cord serum. Acta Obstetricia et Gynecologica Scandinavica 1996; 75: 902-07.
10. Eliopoulos C, Klein J, Chitayat D, Greenwald M, Koren G. Nicotine and cotinine in maternal and neonatal hair as markers of gestational smoking. Clinical and Investigative Medicine 1996; 19: 231-42.
11. Kintz P, Mangin P. Evidence of gestational heroin or nicotine exposure by analysis of fetal hair. Forensic Science International 1993; 63: 99-104.
12. Ostrea EM, Jr., Knapp DK, Romero A, Montes M, Ostrea AR. Meconium analysis to assess fetal exposure to nicotine by active and passive maternal smoking. The Journal of Pediatrics 1994; 124: 471-76.
13. Köhler E, Bretschneider D, Rabsilber A, Weise W, Jorch G. Assessment of prenatal smoke exposure by determining nicotine and its metabolites in maternal and neonatal urine. Human and Experimental Toxicology 2001; 20: 1-7.
14. Koren G. Measurement of drugs in neonatal hair; a window to fetal exposure. Forensic Science International 1995; 70: 77-82.
15. Ostrea EM, Jr. Testing for exposure to illicit drugs and other agents in the neonate: a review of laboratory methods and the role of meconium analysis. Current Problems in Pediatrics 1999; 29: 37-56.
16. Baranowski J, Pochopien G, Baranowska I. Determination of nicotine, cotinine and caffeine in meconium using high-performance liquid chromatography. Journal of Chromatography B 1998; 707: 317-21.
17. Köhler E, Sollich V, Schuster R, Thal W. Passive smoke exposure in infants and children with respiratory tract diseases. Human and Experimental Toxicology 1999; 18: 212-17.
18. Helger R, Rindfrey H, Hilgefeld J. Eine Methode zur direkten Bestimmung des Creatinins im Serum und Urin ohne Enteiweißung nach einer modifizierten Jaffé-Methode. Zeitschrift für klinische Chemie und klinische Biochemie 1974; 12: 344-49.
19. Dempsey D, Moore C, Deitermann D, Lewis D, Feeley B, Niedbala RS. The detection of cotinine in hydrolyzed meconium samples. Forensic Science International 1999; 102: 167-71.
20. Luck W, Nau H, Hansen R, Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Developmental Pharmacology and Therapeutics 1985; 8: 384-95.
21. Rühle W, Graf von Ballestrem CL, Pult HM, Gnirs J. Korrelation des Cotininspiegels in Fruchtwasser, Nabelarterienblut und mutterlichem Blut. Geburtshilfe und Frauenheilkunde 1995; 55: 156-59.
22. Burguet A, Berard M, Woronoff AS, Roth P, Menetrier M, Vanlemmens P, Schaal JP, Menget A. Appréciation du tabagisme maternel et néonatal par un dosage de la cotinine urinaire par chromatographie liquide haute performance. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 2001; 30: 166-73.
23. Schorp MK, Leyden DE. Distribution analysis of airborne nicotine concentrations in hospitality facilities. Environment International 2002; 27: 567-78.
24. Dempsey D, Jacob P, III, Benowitz NL. Nicotine metabolism and elimination kinetics in newborns. Clinical Pharmacology and Therapeutics 2000; 67: 458-65.
25. Benowitz NL, Jacob P, III. Trans-3′-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. British Journal of Clinical Pharmacology 2001; 51: 53-59.
26. Lemahieu WP, Maes BD, Verbeke K, Vanrenterghem Y. Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: consequences for FK506 assimilation. Kidney International 2005; 67: 1152-60.
27. Lindell M, Karlsson MO, Lennernas H, Pahlman L, Lang MA. Variable expression of CYP and Pgp genes in the human small intestine. European Journal of Clinical Investigation 2003; 33: 493-99.
28. Ding X, Kaminsky LS. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annual Review of Pharmacology and Toxicology 2003; 43: 149-73.
29. Moore C, Negrusz A, Lewis D. Determination of drugs of abuse in meconium. Journal of Chromatography B 1998; 713: 137-46.